Search

Takeda Pharmaceutical Co Ltd ADR

Închisă

SectorSănătate

17.64 1.44

Rezumat

Modificarea prețului

24h

Curent

Minim

17.6

Maxim

17.64

Indicatori cheie

By Trading Economics

Venit

138B

113B

Vânzări

105B

1.2T

P/E

Medie Sector

42.622

57.002

EPS

0.48

Randament dividend

3.53

Marjă de profit

9.279

Angajați

47,029

EBITDA

180B

337B

Recomandări

By TipRanks

Recomandări

Cumpărare

Prognoză pe 12 luni

+80.6% upside

Dividende

By Acuity

Randament dividend

Medie Sector

3.53%

2.22%

Statistici piață

By TradingEconomics

Capitalizare de piață

351M

56B

Deschiderea anterioară

16.2

Închiderea anterioară

17.64

Sentimentul știrilor

By Acuity

100%

0%

327 / 340 Clasament în Healthcare

Takeda Pharmaceutical Co Ltd ADR Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

15 aug. 2026, 00:06 UTC

News

Berkshire Hathaway increased its stake in New York Times Co. to 15.7 million shares, contributing to a modest rise in after-market hours.

15 aug. 2026, 00:02 UTC

News

AeroVironment appointed Michael D. Ruppert to its Board of Directors as Charles Burbage plans to retire in 2026. Shares are lower in after-market trading.

15 aug. 2026, 00:02 UTC

News

Shares of Photronics Inc lower in after-hours trading amid a class action lawsuit alleging securities fraud related to misleading statements about its product pipeline.

15 aug. 2026, 00:02 UTC

Social Media
News

Berkshire Hathaway's new position in DR Horton increased investor interest, contributing to a rise in the stock during after-hours trading.

15 aug. 2026, 00:02 UTC

News

Planet Fitness Inc. shares are higher in after-market trading, reflecting positive sentiment following recent performance despite remaining below the 20-day moving average.

15 aug. 2026, 00:02 UTC

News

Berkshire Hathaway has dissolved its stake in Constellation Brands, contributing to a decline in shares during after-market hours. The stock remains above its 20-day moving average.

15 aug. 2026, 00:02 UTC

News

Target Corp shares are lower in after-market hours despite Telsey Advisory Group raising its price target to $170 and maintaining an Outperform rating.

15 aug. 2026, 00:02 UTC

News

Realty Income Corp closed a $1.0 billion private offering of convertible senior notes and is trading higher in after-market hours.

15 aug. 2026, 00:02 UTC

News

Texas Pacific Land shares rise in after-market trading, continuing a trend of gains. The company's market cap stands at $24.75 billion.

15 aug. 2026, 00:01 UTC

News

Soros Fund Management LLC reduced its stake in Blue Owl Capital Inc by 51.8% to 973,500 shares, contributing to negative sentiment. Shares are roughly flat in after-market trading.

15 aug. 2026, 00:01 UTC

News

Elliott Investment Management increased its stake in Hewlett Packard Enterprise to 32.3 million shares. Shares were roughly flat in after-market trading.

15 aug. 2026, 00:01 UTC

News
Social Media

Genco Shipping & Trading shares decline in after-market trading following Diana Shipping's withdrawal of its acquisition offer due to unrealistic demands from Genco's Board.

15 aug. 2026, 00:01 UTC

News

Wix.Com Ltd faces a class action lawsuit over alleged securities law violations related to its AI products, with shares trading lower in after-market hours.

15 aug. 2026, 00:01 UTC

News

Jana Partners disclosed a new stake in Rapid7, contributing to positive sentiment. In after-market trading, shares recovered and traded higher since Friday's close.

15 aug. 2026, 00:01 UTC

News

Embecta Corp shares are lower in after-market trading amid two class action lawsuits alleging securities fraud and a significant revenue decline.

14 aug. 2026, 23:52 UTC

News

Boeing Co secures over $711 million in U.S. defense contract modifications, boosting investor sentiment. Shares are higher in after-market trading.

14 aug. 2026, 23:51 UTC

News

PayPal is in advanced talks for a potential sale to Stripe and Advent, following a proposal of $60.50 per share. Shares are higher in after-market trading.

14 aug. 2026, 23:51 UTC

News

Tyson Foods will close its beef facility in Joslin, Illinois, resulting in about 2,500 job losses, as shares trade lower in after-market hours.

14 aug. 2026, 23:46 UTC

News

Replimune Group Inc shares are lower in after-market hours amid negative sentiment from a securities fraud lawsuit related to its RP1 application.

14 aug. 2026, 23:46 UTC

News

Delek US Holdings shares rose in after-market hours following Delek Logistics Partners' $230 million public offering of common units at $50.00 each.

14 aug. 2026, 23:46 UTC

News

Patterson-UTI Energy reported 98 drilling rigs operating in July. Shares rose in after-market trading, reflecting strong activity and nearing the upper end of their one-month range.

14 aug. 2026, 23:46 UTC

News

Kraft Heinz Co shares are lower in after-market trading following a $100 million marketing announcement and concerns over July's U.S. retail sales drop.

14 aug. 2026, 23:41 UTC

News

Elliott Investment Management increased its stake in Hewlett Packard Enterprise by 17.7%, contributing to higher after-market trading for the shares.

14 aug. 2026, 23:36 UTC

News

Dynatrace shares are higher in after-hours trading following Starboard Value's SEC filing disclosing an 8.9 million share stake.

14 aug. 2026, 23:31 UTC

News

Texas Pacific Land Corp shares are higher in after-market hours, with a current price of $358.89 and a market capitalization of $24.75 billion.

14 aug. 2026, 23:31 UTC

News

Jana Partners disclosed a new stake in Rapid7 Inc, acquiring over 6.7 million shares. Shares advanced during after-market hours following the announcement.

14 aug. 2026, 23:21 UTC

News

MongoDB Inc. showcases AI focus with new Atlas Managed MCP Server tools and Voyage AI features. Shares are little changed in after-market trading.

14 aug. 2026, 23:21 UTC

News

Constellation Brands shares are trading lower after Berkshire Hathaway dissolved its stake, contributing to negative sentiment amid broader weakness in the Distillers & Vintners sector.

14 aug. 2026, 23:21 UTC

News

Embecta Corp shares are lower in after-market hours amid negative sentiment from two class action lawsuits alleging securities fraud and disappointing second-quarter guidance.

14 aug. 2026, 23:11 UTC

News

Lattice Semiconductor granted over 414,000 RSUs and PRSUs to new employees as part of its equity incentive plan. Shares are trading roughly flat in after-market hours.

Comparație

Modificare preț

Takeda Pharmaceutical Co Ltd ADR Așteptări

Obiectiv de preț

By TipRanks

80.6% sus

Prognoză pe 12 luni

Medie 31.84 USD  80.6%

Maxim 42.684 USD

Minim 21 USD

În baza a 2 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruTakeda Pharmaceutical Co Ltd ADR - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Cumpărare

2 ratings

2

Cumpărare

0

Păstrare

0

Vânzare

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Takeda Pharmaceutical Co Ltd ADR

Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived therapies, immunology, oncology, and neuroscience. The company provides its products under the Entyvio, Gattex/Revestive, Takecab/Vocinti, EOHILIA, Alofisel, Dexilant, Pantoloc/Controloc, Adynovate/Adynovi, Feiba, Recombinate, Hemofil/Immunate/Immunine, Takhzyro, Livtencity, ADZYNMA, Elaprase, Replagal, Advate, Flexbumin, Vpriv, Gammagard Liquid/Kiovig, Hyqvia, Cuvitru, Exkivity, FRUZAQLA, Ninlaro, Velcade, Azilva-F, Lotriga, Iclusig, Leuplin/Enantone, Adcetris, vyvanse/elvanse, Trintellix, QDENGA, and Alunbrig brands. It has in-license agreement with BioMarin, Luxna Biotech, GlaxoSmithKline, Halozyme, and Kamada; collaboration with Neurocrine Biosciences, Inc., Seagen Inc., Anima Biotech, Denali Therapeutics, KSQ Therapeutics, Noile-Immune Biotech, Center for iPS Cell Research Application, Kyoto University (CiRA), and Charles River Laboratories; licensing agreement with Mirum Pharmaceuticals and Twist Bioscience, UCSD/Fortis Advisors, PeptiDream, MD Anderson Cancer Center, Teva Pharmaceutical Industries, and Xenetic Biosciences; collaboration and licensing agreement with Arrowhead Pharmaceuticals Inc., Engitix, Genevant Sciences Corporation, Sosei Heptares, Zedira/Dr. Falk Pharma, Exelixis, Inc., GlaxoSmithKline, Heidelberg Pharma, HUTCHMED, Presage Biosciences, Codexis, Inc., Ensoma, Envozyne, KM Biologics, and Selecta BioScience, and Ovid Therapeutics Inc.; and collaboration with ZEDIRA GmbH and Dr. Falk Pharma GmbH. It has research collaboration and licensing agreement with Crescendo Biologics, Code Bio, Immusoft, Poseida Therapeutics, and Selecta Biosciences. The company was founded in 1781 and is headquartered in Tokyo, Japan.
help-icon Live chat